SynBac
Traditional process scale up using baculovirus is notoriously problematic, with yields dropping progressively during scale up. SynBac™ are minimized baculoviral genomes created using modern synthetic biology techniques. The SynBac™ project aims to transform fermenter-scale baculoviral production of drug targets, and manufacturing scale production of biopharmaceuticals by creating minimal baculoviral genomes displaying exceptional DNA stability. In addition to improved DNA stability, our minimized genomes form the starting point for applications that require large DNA cargo delivery to mammalian cells, primary cells, or organs.
17th Oct 2020
Recent Posts
-
NGF (Nerve Growth Factor): A Simple Overview
Nerve Growth Factor, commonly abbreviated as NGF, is a critical protein that plays a pivotal role in …28th Mar 2024 -
Tiny Camelids, Big Antibodies: The Rise of Alpaca Antibodies in Science
Keywords: Alpaca antibodies, camelids, single-domain antibodies (VHHs), antigen binding, conventiona …28th Mar 2024 -
Understanding ABCA1: A Simple Guide
When it comes to cholesterol metabolism and lipid transport, the ABCA1 protein plays a crucial role. …28th Mar 2024